BRINGING YOU INFORMATION.  PROVIDING YOU A PLATFORM.

 

 
THE PHARMA REVIEW (SEPTEMBER OCTOBER 2012)

Current Status of Pharmaceutical Patenting at United States Patent Office

Rau. B. S & Appaji P. V

Introduction:
 
Globally, patent system in United States of America is one of the well-established systems. Most of the countries patent their pharmaceutical innovations, products especially, in United States, since; United States (US) is not only of the largest market but also due to the fact that Patent Laws are stringently enforced in United States. While the US Patent and Trademark Office (USPTO) have exclusive patent classification for US Patents, it can, however, be correlated to International Patent Classification (IPC). Among the utility, plant and design patents, the present article deals with utility patents relating to pharmaceutical products. Classes 424, 514 of United States Patent Classification (USPC) mainly deal with pharmaceutical product approximations. The data available at USPTO provides the current status of - countries patenting their pharmaceutical products especially in United States of America.
India is one of the top twenty leading exporters of pharmaceutical products, with the top pharma manufacturers directing their business towards developed countries. As per Directorate General of Commercial Intelligence and Statistics, India has export value of US $ 13,211 mn to the World, out of which the export value of US $ 3, 254 mn is to United States in the field of Drugs, Pharmaceuticals and Fine Chemicals for the financial year Apr’11-Mar’12.

 

 

Go to Content Index Page

PHARMA REVIEW - ARTICLES ARCHIVE ( COMPLETE LIST)

 

The above content is an abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate, New Delhi, India -110016
Tel.: 26855839, 9811195411
Email: kongposhpub@gmail.com, Website: http://www.kppub.com

 
 
 
 

Copyright KONGPOSH PUBLICATIONS Pvt. Ltd.